Related Experiment Video
Updated: Apr 27, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
7.7K
Aspirin for primary cardiovascular prevention: when is it worth the risks?
1Professor and Vice Chair, Department of Pharmacy Practice, University of Kansas Medical Center , Mailstop 4047, 3901 Rainbow Boulevard, Kansas City, KS 66160 ; phone: 913-588-5391 ; fax: 913-588-2355 ;
Hospital Pharmacy
|June 25, 2014
Summary
Low-dose aspirin is commonly used for preventing heart attack and stroke, but its effectiveness and safety are not definitively proven. Further research is needed to clarify its benefits and risks for widespread use.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Low-dose aspirin is frequently used for primary prevention of myocardial infarction and stroke.
- Despite widespread use, conclusive evidence supporting its efficacy and safety remains limited.
Purpose of the Study:
- To evaluate the conclusive evidence for low-dose aspirin in primary prevention of myocardial infarction and stroke.
- To address inconsistencies in current practice guidelines and unanswered questions regarding aspirin use.
Main Methods:
- Systematic review of existing clinical trials and epidemiological studies.
- Analysis of data on aspirin's efficacy, safety profile, and risk-benefit ratio.
Main Results:
- Evidence regarding the effectiveness of low-dose aspirin for primary prevention is inconclusive.
- Current guidelines exhibit inconsistencies, highlighting a need for clearer recommendations.
Conclusions:
- The definitive role of low-dose aspirin in primary prevention requires further investigation.
- Pharmacists play a crucial role in patient counseling due to aspirin's over-the-counter availability.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:26Atherosclerosis III: Management
723
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
723
01:26Coronary Artery Disease IV: Preventive Measures
888
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
01:27Peripheral Artery Disease III: Interprofessional Care
653
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
01:27Coronary Artery Disease V: Interprofessional Care
442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
965
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
965